Financials
Financial year 2025
APOTHEEK VALCKE from Wervik, company number BE0413980756, closed financial year 2025 with a result of € 30,076 after tax. For that financial year APOTHEEK VALCKE recorded a gross margin of € 27,737 and equity of € 86,505. Compared with financial year 2024, the result moved from € 41,789 to € 30,076. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
€ 86,505
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 30,076
▼ 28% vs 2024
Profit after tax over the fiscal year.
€ 8,327
▲ € 7,614 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 30,075 paid out
100 % of the profit went to the shareholders, mostly to INVEDA (100 % of the shares). That is where the money ends up.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,290
▼ 69% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 56,864 | € 53,602 | € 44,117 | € 27,737 | ▼ 37% |
| Profit after taxes | € 26,379 | € 30,563 | € 41,789 | € 30,076 | ▼ 28% |
| Equity | € 505,937 | € 536,500 | € 86,505 | € 86,505 | |
| Total debts | € 6,677 | € 5,118 | € 499,271 | € 482,365 | ▼ 3% |
| Cash | € 2,411 | € 1,358 | € 712 | € 8,327 | ▲ € 7,614 |
| Land & buildings | € 169,214 | € 158,344 | € 153,559 | € 148,839 | ▼ 3% |
| Retained profit | € 443,964 | € 474,527 | € 24,531 | € 24,532 | |
| Dividend | € 0 | € 0 | € 491,785 | € 30,075 | ▼ 94% |
| Bank debt | € 0 | € 175 | € 0 | € 0 | |
| Balance sheet total | € 512,614 | € 541,618 | € 585,776 | € 568,871 | ▼ 3% |
Key figures of APOTHEEK VALCKE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK VALCKE?
What happened at APOTHEEK VALCKE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 30,076 (▼ 28% vs 2024). Source: NBB ↗
- Dema BV became a director. NBB
- Ansopharma Comm V became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Wervik. KBO
In short
From € 26,379 profit in 2022 to € 30,076 profit in 2025.
Paid € 19,182 in corporate taxes since 2022.
Best year ever: 2024, with € 41,789 profit.
Paid out € 521,860 in dividends to the owners in total.
Management
The stake of INVEDA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK VALCKEBehind APOTHEEK VALCKE are Dema BV and Ansopharma Comm V. The shares are held by INVEDA (100%).
Directors
According to the 2025 annual accounts
since 2024
Managing director · represented by Leroy Ann-Sophie
Also active at: APOTHEEK ANN-SOPHIE LEROY, Apotheek Leroy Geluwe
since 2024
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Vrouwstraat 5
8940 Wervik
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0413.980.756
- VAT number
- BE 0413.980.756
- Registered office
- Vrouwstraat 5, 8940 Wervik
- Names & denominations
- APOTHEEK VALCKE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 January 1974
- Peppol
- Active · Active since 25 Apr 2025
- Activities · NACE
Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen